(Q38996304)

8 September 2017

title

Huaier suppresses proliferation and induces apoptosis in human pulmonary cancer cells via upregulation of miR-26b-5p (English)

1 reference

8 September 2017

Tangwei Wu

1

1 reference

8 September 2017

Weiqun Chen

2

1 reference

8 September 2017

Shuiyi Liu

3

1 reference

8 September 2017

Hongda Lu

4

1 reference

8 September 2017

Hui Wang

5

1 reference

8 September 2017

Deyong Kong

6

1 reference

8 September 2017

Xiaodong Huang

7

1 reference

8 September 2017

Qinzhi Kong

8

1 reference

8 September 2017

Yong Ning

9

1 reference

8 September 2017

Zhongxin Lu

10

1 reference

8 September 2017

language of work or name

English

0 references

publication date

8 May 2014

1 reference

8 September 2017

1 reference

8 September 2017

volume

588

1 reference

8 September 2017

issue

12

1 reference

8 September 2017

page(s)

2107-2114

1 reference

8 September 2017

cites work

Cancer statistics, 2013

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2014.04.044

Oral Chinese herbal medicine (CHM) as an adjuvant treatment during chemotherapy for non-small cell lung cancer: A systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2014.04.044

Huaier aqueous extract inhibits proliferation of breast cancer cells by inducing apoptosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2014.04.044

miR-511 and miR-1297 inhibit human lung adenocarcinoma cell proliferation by targeting oncogene TRIB2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2014.04.044

MicroRNA-21 gene and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2014.04.044

miRBase: integrating microRNA annotation and deep-sequencing data

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2014.04.044

Coordinated regulation of polycomb group complexes through microRNAs in cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2014.04.044

Clinicopathological significance of EZH2 mRNA expression in patients with hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2014.04.044

Huaier aqueous extract inhibits ovarian cancer cell motility via the AKT/GSK3β/β-catenin pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2014.04.044

MicroRNA profiling in lung cancer reveals new molecular markers for diagnosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2014.04.044

MicroRNA-26b is underexpressed in human breast cancer and induces cell apoptosis by targeting SLC7A11

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2014.04.044

MiRNA-26b inhibits proliferation by targeting PTGS2 in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2014.04.044

Role of microRNA-26b in glioma development and its mediated regulation on EphA2

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2014.04.044

Ovarian cancer stem cell-like side populations are enriched following chemotherapy and overexpress EZH2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2014.04.044

EZH2, an epigenetic driver of prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2014.04.044

Enhancer of zeste homolog 2 is a novel prognostic biomarker in nonsmall cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2014.04.044

EZH2 promotes proliferation and invasiveness of prostate cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2014.04.044

Downregulation of EZH2 decreases growth of estrogen receptor-negative invasive breast carcinoma and requires BRCA1

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2014.04.044

The enhancer of zeste homolog 2 (EZH2), a potential therapeutic target, is regulated by miR-101 in renal cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2014.04.044

Genomic loss of microRNA-101 leads to overexpression of histone methyltransferase EZH2 in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2014.04.044

Analysing the impact of nucleo-cytoplasmic shuttling of β-catenin and its antagonists APC, Axin and GSK3 on Wnt/β-catenin signalling

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2014.04.044

EZH2-mediated concordant repression of Wnt antagonists promotes β-catenin-dependent hepatocarcinogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2014.04.044

miR-144 downregulation increases bladder cancer cell proliferation by targeting EZH2 and regulating Wnt signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2014.04.044

Bcl-2 overexpression in PhIP-induced colon tumors: cloning of the rat Bcl-2 promoter and characterization of a pathway involving beta-catenin, c-Myc and E2F1

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2014.04.044

10.1016/J.FEBSLET.2014.04.044

21 January 2018

Identifiers

DOI

1 reference

8 September 2017

1 reference